Citius (CTXR). Dang Flippers!
Short term investors powered Citius from $2.50 to near $4.50 in hopes of a positive early trial halt for Mino-Lok® (a rare but potential...
Teplizumab: Can We Delay the Onset of Type 1? (DiaTribe)
Teplizumab: Can We Delay the Onset of Type 1?
Last updated: 6/7/21
By Dr. Francine Kaufman
Provention Bio’s new injectable drug was recommended by an FDA committee...
Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in Stem Cell and...
- Addition of leading scholar and KOL in acute respiratory distress syndrome (ARDS) to ARDS Scientific Advisory Board supports continued progress of Citius' novel...
More Great News From Citius Pharma (CTXR).
UPDATED CHART 6-15-21
Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
We're up 370% since adding it to the Biotech Stock Review Watch List...
Stocks On The Move!
Citius (CTXR) up 19%, Draganfly (DFLYF) up 31%, urban-gro (UGRO) up 37%, Provention (PVRB) flip-flopping, Hapbee Technologies (HAPBF) up 26% and the Alkaline Water...
Provention Bio (PRVB) Updates.
LATEST UPDATE July 13th, 2022, below.
(2021) We're getting way too many calls on this. We'll try to put a blow by blow here. Nothing...
Adding Hapbee Tech (HAPB, HAPBF) $0.34 to Biotech Six Pack Watch List.
UPDATE ON BIOTECH SIX PACK, SIX STOCKS WE EXPECT TO DOUBLE.
While the Biotech Stock Review was launched in 2002, the "Biotech 6-Pack, 6 Stocks...
Citius Pharma (CTXR) Updates Shareholders.
Citius Update Stem Cell Study
Citius Pharmaceuticals, Inc announced that it will present a poster at the International Society for Cell and Gene Therapy (ISCT)...
Interview: Citius Pharma (CTXR) $1.74, Chairman Leonard Mazur.
https://youtu.be/vMIy8xWLOKI?t=3699
INSIDER HOLDINGS
POWERPOINT
LIVE CHART
Adding Citius (CTXR) $0.55 to Watch List.
Citius News Archive
MARKET BEAT
TIP RANKS
Disclaimer. Citius Pharma is a client, please see reports for disclosure and...
Interview: Scott Donnell from Hapbee (HAPB, HAPBF) on Wall Street Reporter.
Transcript follows.
Hapbee CEO Live with the Wall Street Reporter
Listen in as Hapbee CEO Scott Donnell chats with the Wall Street Reporter about all things...